Creative Financial Designs Inc. ADV Sells 317 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Creative Financial Designs Inc. ADV reduced its holdings in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,313 shares of the company’s stock after selling 317 shares during the quarter. Creative Financial Designs Inc. ADV owned 0.13% of Invesco Biotechnology & Genome ETF worth $353,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Howe & Rusling Inc. bought a new stake in shares of Invesco Biotechnology & Genome ETF during the 3rd quarter worth $31,000. Jones Financial Companies Lllp raised its position in Invesco Biotechnology & Genome ETF by 52.9% in the fourth quarter. Jones Financial Companies Lllp now owns 2,315 shares of the company’s stock valued at $154,000 after purchasing an additional 801 shares during the last quarter. Farther Finance Advisors LLC bought a new position in Invesco Biotechnology & Genome ETF in the fourth quarter valued at about $161,000. Jane Street Group LLC bought a new position in Invesco Biotechnology & Genome ETF in the third quarter valued at about $295,000. Finally, HighTower Advisors LLC raised its position in Invesco Biotechnology & Genome ETF by 64.1% in the third quarter. HighTower Advisors LLC now owns 7,101 shares of the company’s stock valued at $494,000 after purchasing an additional 2,774 shares during the last quarter.

Invesco Biotechnology & Genome ETF Trading Down 1.0 %

Invesco Biotechnology & Genome ETF stock opened at $65.56 on Wednesday. The company has a market capitalization of $239.95 million, a PE ratio of 22.64 and a beta of 0.80. Invesco Biotechnology & Genome ETF has a 12 month low of $59.32 and a 12 month high of $72.84. The stock has a 50-day moving average price of $67.65 and a two-hundred day moving average price of $68.61.

Invesco Biotechnology & Genome ETF Profile

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.